Daniel J. Marston, etc.,al. [preprint]Iterative immunogen optimization to focus elicited responses on a conserved, subdominant influenza hemagglutinin epitope. https://doi.org/10.1101/2025.11.04.686334
Designing effective vaccination strategies against genetically diverse viruses, such as HIV or influenza, is hindered by the ability of these pathogens to mutate and readily evade immune control. While these viruses contain conserved regions that cannot easily mutate without affecting viral fitness, these sites are subdominant, meaning that they are not the primary target of immune responses elicited by natural infection or current vaccines. Here, we integrated recent advances in machine learning methods for protein structure prediction and design to engineer protein immunogens that focus immune responses on a conserved, subdominant HA epitope targeted by broadly cross-reactive influenza antibodies. Iterating between computation-guided optimization and in vivo analyses generated immunogens that faithfully displayed the target epitope and redirected humoral responses toward it upon vaccination. These results provide a blueprint for applying recent protein engineering approaches to immunogen design and may inform the design of broadly protective influenza vaccines.
See Also:
Latest articles in those days:
- MHC class II functions as a host-specific entry receptor for representative human and swine H3N2 influenza A viruses 1 minute(s) ago
- Longitudinal Surveillance of Influenza A Virus Exposure in Wild Boars (Sus scrofa) in Spain (2015-2023): Serologic and Virologic Evidence of Subtype Infections and H5N1 Spillover Risk 3 minute(s) ago
- [preprint]Emergence and antigenic characterisation of influenza A(H3N2) viruses with hemagglutinin substitutions N158K and K189R during the 2024/25 influenza season 19 hours ago
- Epitope specificity shapes the CD4+ T cell response to influenza virus infection in mice 19 hours ago
- Vaccination against H5 HP avian influenza virus leads to persistent immune response in wild king penguins 1 days ago
[Go Top] [Close Window]


